These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 191534

  • 21. Cell-mediated anti-tumor response in the RLmale 1 system. I. T nature, H-2Dd involvement and antigenic specificity of the effector cells.
    Duprez V, Gomard E, Levy JP.
    Eur J Immunol; 1978 Sep; 8(9):650-5. PubMed ID: 81780
    [No Abstract] [Full Text] [Related]

  • 22. Humoral regulation of cell-mediated immunity to syngeneic tumor.
    Ting CC.
    Cancer Res; 1976 Oct; 36(10):3695-701. PubMed ID: 953995
    [Abstract] [Full Text] [Related]

  • 23. Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigens.
    Fujiwara H, Hamaoka T, Teshima K, Aoki H, Kitagawa M.
    Immunology; 1976 Aug; 31(2):239-48. PubMed ID: 1085283
    [Abstract] [Full Text] [Related]

  • 24. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 25. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M, Uharek L, Glass B, Gaska T, Gassmann W, Mueller-Ruchholtz W.
    Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
    [Abstract] [Full Text] [Related]

  • 26. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF, Dennert G, Lennox ES.
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Activity of tumor-associated lymphoid cells at short intervals after administration of irradiated syngeneic and allogeneic tumor cells.
    Schick B, Berke G.
    J Immunol; 1977 Mar; 118(3):986-91. PubMed ID: 321684
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J, Saffold S, Cao X, Krauss J, Chen W.
    J Immunol; 1998 Nov 15; 161(10):5516-24. PubMed ID: 9820528
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Immunologic mechanisms in the pathogenesis of virus-induced murine leukemia. III. Target cell specificity of autoreactive thymocytes.
    Proffitt MR, Hirsch MS, Ellis DA, Gheridian B, Black PH.
    J Immunol; 1976 Jul 15; 117(1):11-5. PubMed ID: 180178
    [Abstract] [Full Text] [Related]

  • 35. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ, Howe ML.
    J Immunol; 1979 May 15; 122(5):1874-80. PubMed ID: 221580
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW, Whitten HD, Skurzak HM, Andersson B, Lidin B.
    J Immunol; 1975 Nov 15; 115(5):1288-94. PubMed ID: 1080777
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.